This study is based on the Swiss Canine Cancer Registry, comprising 121,963 diagnostic records of dogs compiled between 1955 and 2008, in which 63,214 (51.83%) animals were diagnosed with tumour lesions through microscopical investigation. Adenoma/adenocarcinoma (n ¼ 12,293, 18.09%) was the most frequent tumour diagnosis. Other common tumour diagnoses were: mast cell tumour (n ¼ 4,415, 6.50%), lymphoma (n ¼ 2,955, 4.35%), melanocytic tumours (n ¼ 2,466, 3.63%), fibroma/fibrosarcoma (n ¼ 2,309, 3.40%), haemangioma/haemangiosarcoma (n ¼ 1,904, 2.80%), squamous cell carcinoma (n ¼ 1,324, 1.95%) and osteoma/ osteosarcoma (n ¼ 842, 1.24%). The relative occurrence over time and the most common body locations of those tumour diagnoses are presented.
Introduction
To meet the challenge posed by the combination of potential aetiological factors in cancer, patient data and diagnoses need to be explored systematically (MacVean et al., 1978; Brønden et al., 2007 Brønden et al., , 2010 Vascellari et al., 2009; Dobson, 2013; Waters et al., 2014) . This is the cornerstone of any epidemiological study of cancer that aims to investigate cancer development patterns in defined populations over time and space. The epidemiological study of cancer is therefore dependent on the availability of patient data, which are usually stored in cancer registries.
In this context, the study of companion animal cancer registries is especially valuable. Firstly, companion animals and their owners share the same environment and are therefore mostly exposed to the same environmental cancer risk factors (Bukowski and Wartenberg, 1997; Backer et al., 2001; Gamlem et al., 2008; Marconato et al., 2009; Bettini et al., 2010) . Secondly, similar genetic predisposing factors for cancer development have been found for man and animals (J onasd ottir et al., 2000; Patterson, 2000; Lingaas et al., 2003; Breen, 2009; Pastor et al., 2009; Phillips et al., 2010; Ke et al., 2011) . For instance, canine renal cystadenocarcinoma and nodular dermatofibrosis (J onasd ottir et al., 2000; Lingaas et al., 2003) and canine osteosarcoma (Phillips et al., 2010) are wellknown examples of syndromes linked to genetic conditions common to both dogs and man. The former complex was linked to a specific mutation also found in people affected by a similar syndrome; in the latter a linkage to a specific locus was found in both species. These findings underline the value of comparative studies in human and veterinary oncology as part of the 'One Health' concept (Breen, 2009) .
The present study is based on the Swiss Canine Cancer Registry (Gr€ untzig et al., 2015) and highlights the influences of age, breed, body size, sex and neutering status on the development of tumours in dogs. The size of the Swiss Canine Cancer Registry, which comprises 121,963 dogs and 67,943 tumour diagnoses, allows computation of meaningful statistics. To our knowledge, the Swiss Canine Cancer Registry is the most comprehensive animal cancer registry at a national level.
Materials and Methods

Data Source
The data originated from the Swiss Canine Cancer Registry (Gr€ untzig et al., 2015) comprising 121,963 diagnostic records of dogs provided by three veterinary diagnostic laboratories in Switzerland: the Vetsuisse Faculty Institut f€ ur Veterin€ arpathologie, Z€ urich (IVPZ), the Vetsuisse Faculty Institut f€ ur Tierpathologie, Bern (ITPA) and the Zyto/Histo Diagnostik private veterinary diagnostic laboratory (based in Rorbas Freienstein). The data sets included diagnostic records from canine samples generated by three different examination methods: post-mortem analysis (and subsequent histopathological evaluation), biopsy sampling (with subsequent histopathological examination) and cytology. Biopsy and cytology samples are hereafter called ex-vivo samples. No cases were excluded; however, some parameters were missing due to incomplete reporting by the submitting veterinarians. All diagnoses in the Swiss Canine Cancer Registry were derived from a microscopical examination.
Data Preparation
In different time periods, different terms were used for the description of age, breed, sex and neutering status. Those differences were standardized by numerical coding. The diagnoses were then coded according to the tumour topographical and morphological keys of the ICD-O-3 (Fritz et al., 2013) and checked for plausibility using the original patient records. All tumour diagnoses were based on either histopathological or cytological examination. Epidermal cysts were excluded.
The data included 215 castrated male dogs with tumours in the testes. Since it is common in those cases to castrate the patient while sampling the tumour, those dogs where re-classified as entire at the moment of tumour diagnosis.
Data sets missing the information on the sex and/or status of neutering of patients were excluded from the evaluation of the influence of these parameters on tumour development.
Breed allocation was based on information available in the diagnostic records, which was usually provided by the pet owner or by the submitting veterinarian. A declaration of one breed was accepted as reported, while a declaration comprising two breeds (in the case of an apparent mix with recognizable breeds) was categorized according to the breed mentioned first (i.e. a shepherd-cross was categorized under shepherd, a shepherdeboxer-cross likewise under shepherd and a boxereshepherd-cross under boxer). It was assumed that the breed mentioned first was the one more obvious from the external appearance. Therefore, the breeds defined in this work cannot be considered pure breeds and a certain influence of mixed breeding must be acknowledged in the risk calculations. The proportion of manifestly nonpure breeds ranged between 0 and 18% in the breeds considered for analysis (Table 1) . Because all such mixed breeds likely share at least 50% of their genetic information with the predominant breed, content of non-breed related genome is maximally 50% in these animals. This should be taken into account while interpreting the results of the statistics. As an example, for the Swiss mountain dog, the breed with the highest proportion of manifestly crossed individuals (18.4%), the unrelated genome may theoretically account for a difference of 9% in the odds ratio (OR).
A non-specific allocation such as mixed-breed, mongrel or crossbreed was categorized under crossbreed, since it was assumed that a phenotype typical for a known breed was lacking or not distinct.
The breeds/breed categories most frequently represented in the data set, each comprising at least 900 individuals, were retained for analysis of risks related to breed (Table 1 ). In a preliminary investigation, the breed ranking of the data set and the breed ranking of the Swiss dog population was compared in those years in which a reference population with known breed composition was available for use as a control (1963, 1999 and 2008) (Pospischil et al., 2013) . For those years the patient breed ranking correlated with that of the reference population, meaning that there was no significant difference in breed distribution between the Swiss dog population and the patient collective. The difference in the distribution of the individual breeds over time was controlled for year and proportional distribution.
The remaining breeds and the diagnostic records with unknown breeds were listed as 'other breeds'. The breed category Swiss mountain dog includes Appenzeller mountain dogs, Bernese mountain dogs, Entlebucher mountain dogs, large Swiss mountain dogs, Swiss mountain dogs and mountain dogs. The breed category retriever includes Chesapeake Bay retriever, curly coated retriever, flat coated retriever, golden retriever, Labrador, Nova Scotia duck tolling retriever, retriever and sandriner (golden retriever For the examination of the influence of body size on tumour development two groups were established. 'Large breeds' comprised the dobermann, Great Dane, retriever, rottweiler, Swiss mountain dogs, shepherd and setter. 'Small breeds' comprised the bulldog, dachshund, Parson Jack Russell, West Highland white terrier and Yorkshire terrier.
Statistical Evaluation
Data editing and statistical analyses were performed using Stata Software (Stata Corp., 2011; Stata Statistical Software: Release 12; College Station, Texas, USA). Statistical analyses were carried out using a Chi-Square/Fisher's exact test. Significant univariable variables were further integrated in a multiple logistic regression model using binary logistic models and stepwise backward procedure. The following variables were included in the model as fixed terms: sex, neutering status, breed, age, year, method of examination and canton of origin. The first four variables are random variables related to the animals and were also used for the specific evaluations on cancer frequency. The three latter variables were random factors related to time, examination method and spatial distribution. The underlying Stata model for the multiple logistic regression was <logistic vary varx1 varx2 varx3 varx4 varx5 varx6 varx7>,
varx6 ¼ method of examination, varx7 ¼ canton of origin. P <0.05 was considered to be significant and ORs with 95% confidence intervals (CIs) were calculated. The power was set at 0.8. In the statistical evaluation, crossbreeds were used as the standard for comparisons with the remaining breeds, since they were assumed to have the largest genetic variation. For the evaluation of influence of sex and neutering status ( Fig. 6 ) on overall tumour development, the data were divided into two subsets based on the examination method: post-mortem samples and ex-vivo samples. The results of the following three groups were compared: post-mortem samples, ex-vivo samples and all samples. For the evaluation of the influence of sex and neutering status on most common tumour diagnoses and locations (Tables 2e4), the total data set (all samples) was compared with the post-mortem sample data subset. The analyses of the influence of age on specific tumour development was biased by the low number of cases aged >15 years. Therefore, results are shown until the age of 15.
Results
The Swiss Canine Cancer Registry consists of records from 126,693 dogs that underwent pathological examination. The number of patients with confirmed tumours was 63,214 (51.83%). Some dogs were diagnosed with multiple primary tumours, adding up to a total of 67,943 diagnosed tumour lesions.
The age distribution has been previously presented (Gr€ untzig et al., 2015) . A large number of the dogs were crossbred (n ¼ 12,193; 10.00%). Breed distribution is given in The following results show the influence of breed on the most common tumour types, as well as of age, body size, sex and neutering status on the overall and specific tumour occurrence. In addition, the influence of sex and neutering status on the anatomical locations is reported. Their occurrence patterns over the years are also included. The classification and distribution of the tumour species of the data set is presented in Supplementary Table 1 .
Adenomas/adenocarcinomas (n ¼ 12,293, 18.09%) were the most common tumour diagnosed overall. From 1955 to 1985, approximately 30e40% of the diagnosed tumours were adenomas/adenocarcinomas. After 1985, the frequency of these diagnoses progressively dropped to 12% in 2008 ( Fig. 1 ). Adenomas/adenocarcinomas were most commonly diagnosed in the mammary gland (n ¼ 6,805; 55.36%) and in the gastrointestinal tract (n ¼ 1,020; 8.30%). Using multiple regression analysis, the ORs of the dog breeds/breed categories developing an adenoma/adenocarcinoma were compared with those of the crossbreds (OR ¼ 1). The Yorkshire terrier, the poodle, the cocker spaniel, the collie, the dachshund and the West Highland white terrier presented with significantly higher ORs in comparison with crossbreds and the other breeds/breed categories included in the analysis. Breeds/breed categories with lower ORs were the rottweiler, the Great Dane, the bulldog, the retriever, the dobermann, the schnauzer, the Swiss mountain dog, the setter, the boxer and the shepherd (Fig. 2 ).
Mast Cell Tumours (ICD-O 9740)
Among the 67,943 neoplasms, 4,415 (6.50%) were diagnosed as a mast cell tumour. Between 1955 and 2008 the relative frequency of mast cell tumours rose with considerable fluctuations from 2.1% to 8.4% of the overall tumour diagnoses (Fig. 1 ). Mast cell tumours (n ¼ 4,415) were mainly diagnosed in the skin (n ¼ 4,324; 97.94%). The boxer showed outstanding significantly higher ORs of developing a mast cell tumour in comparison with crossbreds Table 3 Risk of developing the most common tumour types, comparing neutering status and sampling methods
Tumour type
Neutered males compared with entire males (OR ¼ 1) Neutered females compared with entire females (OR ¼ 1)
In 
Analysis of the Swiss Canine Cancer Registry
and to the other breeds/breed categories. Other breeds with higher risk were the Swiss mountain dogs, the retriever, the bulldog and the Parson Jack Russell terrier. Breeds/breed categories with lower ORs were the collie, the rottweiler, the West Highland white terrier, the shepherd, the poodle, the Yorkshire terrier, the cocker spaniel, the dobermann and the dachshund (Fig. 2) .
Lymphoma 9591, 9700) Among the 67,943 diagnosed tumours, 2,955 (4.35%) were lymphomas. Between 1955 and 2008 the relative frequency of lymphoma decreased from 6.52% to 3.97% per year and from 1968 to 1988 it was around 2% (Fig. 1) . Lymphomas (n ¼ 2,955) were most commonly diagnosed in the lymph nodes (n ¼ 1,362; 46.09%) and in unspecified locations (n ¼ 425; 14.38%), followed by the blood and haemopoietic system (n ¼ 380; 12.86%), skin (n ¼ 234; 7.92%), the spleen (n ¼ 206; 6.97%) and the liver (n ¼ 69; 2.34%). Logistic regression revealed that the rottweiler has a markedly higher OR of developing a lymphoma than crossbreds and other breeds/breed categories included in the analysis. Another breed category with higher ORs was the Swiss mountain dog. The poodle, the Yorkshire ter-rier, the dachshund, the retriever and the shepherd had lower ORs for lymphoma ( Fig. 2 ).
Melanocytic Tumours (ICD-O 8720, 8730)
Among the 67,943 neoplasms diagnosed, 2,466 (3.63%) were melanocytic tumours. From 1955 to 2008 the relative frequency of melanocytic tumours rose from under 2% to over 4% (Fig. 1) . The most common anatomical locations for melanocytic tumours (n ¼ 2,466) were the skin (n ¼ 2,309; 93.6%) and the oral cavity/nasopharynx (n ¼ 106; 4.3%). Multiple regression analysis revealed that the ORs for the following dog breeds/breed categories of developing a melanocytic tumour were higher than those of crossbreds and the other breeds/breed categories included in the analysis: the setter, the schnauzer, the rottweiler, the retriever, the poodle, the dobermann, the dachshund and the cocker spaniel. The bulldog, the West Highland white terrier, the collie, the boxer and the Great Dane presented with lower ORs for melanocytic tumours (Fig. 2) .
Fibroma/Fibrosarcoma 8812) Among the 67,943 tumours, 2,309 (3.40%) were diagnosed as a fibroma/fibrosarcoma. Between 1960 and 1996 the relative frequency of fibroma/ 1 9 5 9 1 9 6 4 1 9 6 9 1 9 7 4 1 9 7 9 1 9 8 4 1 9 8 9 1 9 9 4 1 9 9 9 2 0 0 4 0 10 20 30 40 50
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Year % Mast cell tumour Lymphoma 1 9 5 9 1 9 6 4 1 9 6 9 1 9 7 4 1 9 7 9 1 9 8 4 1 9 8 9 1 9 9 4 1 9 9 9 2 0 0 4 fibrosarcoma increased with several fluctuations from 1.16% to 6.71% of the total tumour number. From 1996 to 2008 their relative frequency was between 2.10% and 3.56% (Fig. 1) . The most common anatomical locations for fibroma/fibrosarcoma (n ¼ 2,309) were the soft tissues (n ¼ 1,080; 46.77%) and the skin (n ¼ 1,040; 45.04%). The setter, the Swiss mountain dog, the rottweiler, the retriever, the dobermann, the boxer and the shepherd had higher ORs of developing fibroma/fibrosarcoma than did crossbreds and the other breeds/breed categories included in the analysis. The West Highland white terrier, the Yorkshire terrier, the dachshund and the poodle presented with lower ORs for fibroma/fibrosarcoma (Fig. 2) .
Haemangioma/Haemangiosarcoma (ICD-O 9120, 9121)
Among the 67,943 diagnosed tumours, 1,904 (2.80%) were a haemangioma/haemangiosarcoma. Between 1955 and 2008 the relative frequency of these tumours rose from 0 to 3.45%, reaching a peak of 7.92% in 1996 (Fig. 1) . The most common anatomical locations for haemangioma/haemangiosarcoma (n ¼ 1,904) were soft tissues (n ¼ 1,203, 63.18%) and the skin (n ¼ 459; 24.11%), followed by the blood/ haemopoietic system (n ¼ 113; 5.93%). The shepherd (OR 1.806 [CI ¼ 1.518, 2.150]) and the boxer (OR 1.850 [CI ¼ 1.506, 2.261]) showed higher ORs of developing a haemangioma/haemangiosarcoma than crossbreds and the other breeds/breed categories included in the analysis. The West Highland white terrier, the Yorkshire terrier, the rottweiler, the poodle, the dobermann, the Great Dane, the cocker spaniel and the dachshund presented with lower ORs for haemangioma/haemangiosarcoma (Fig. 2) .
Squamous Cell Carcinoma 8071, 8078) Among the 67,943 tumours, 1,324 (1.95%) were diagnosed as a squamous cell carcinoma. After a peak of 7.46% in 1958 the relative frequency of squamous cell carcinoma fluctuated between 0.94% and 4.02% of the overall tumour diagnoses until 1999. From 2000 to 2008 it was between 1.47% and 2.29% (Fig. 1) . The high numbers in the 1950s might result from a bias due to the low amount of tumour data available from this period. The most common anatomical locations for squamous cell carcinoma (n ¼ 1,324) were unspecified locations (n ¼ 615; 46.5%), the skin (n ¼ 601; 45.4%) and the oral cavity/nasopharynx (n ¼ 56; 4.23%). Here, results for the schnauzer revealed a seven-fold higher risk (OR 7.712 [CI ¼ 6.031, 9.860]) of developing a squamous cell carcinoma than the other breeds/breed categories included in the analysis. The boxer presented with a lower OR for squamous cell carcinoma (Fig. 2) .
Osteoma/Osteosarcoma (ICD-O 9180)
Among the 67,943 tumours, 842 (1.24%) were diagnosed as an osteoma/osteosarcoma. From 1955 to the late 1960s the relative frequency of osteoma/osteosarcoma was variable, ranging between 6% and 0% of the overall tumour diagnoses. In the 1970s and 1980s it was constantly under 1%. Up to 2008 it rose to 1.56%, with two peaks over 2% in the 1990s (Fig. 1) . The most common anatomical locations for osteoma/ osteosarcoma were bones and joints (n ¼ 746; 88.60%), followed by skin (n ¼ 26; 3.08%). The rottweiler (OR 3.321 [CI ¼ 2.321, 4.752]) and the Great Dane (OR 1.936 [CI ¼ 1.248, 3.003]) presented with a higher risk of developing an osteoma/osteosarcoma than crossbreds and the other breeds/breed categories included in the analysis. The bulldog, the dachshund, the West Highland white terrier, the Parson Jack Russell terrier, the Yorkshire terrier, the poodle, the cocker spaniel and the schnauzer presented with lower ORs for osteoma/osteosarcoma (Fig. 2) .
Influence of Age on Overall Tumour Development
Analyses of the influence of age revealed that the risk of developing adenoma/adenocarcinoma, melanocytic tumours and squamous cell carcinoma increased almost constantly with age. The risk of developing mast cell tumours, fibroma/fibrosarcoma, haemangioma/haemangiosarcoma and osteoma/osteosarcoma was only moderately influenced by increasing Fig. 3 . Odds ratios (ORs) and 95% confidence intervals (CIs) for patients at different ages of developing different tumour types compared with patients aged <1 year (OR ¼ 1). The number of observations was: 126,692 for adenoma/ adenocarcinoma and 126,665 for lymphoma.
age after the age of 3, 4, 5 and 6 years, respectively. The risk of developing a lymphoma increased constantly with age until 6 years and decreased thereafter ( Figs. 3 and 4 ). 
Influence of Sex and Neutering Status on Overall Tumour Development
A closer look at the influence of sex and neutering status on overall tumour prevalence showed that the results depend on the examination method (Fig. 6) (Fig. 6 ).
Influence of Sex and Neutering Status on Specific Tumour Development
Hereafter, only results significant in both investigated groups (i.e. the total data set and the subset of postmortem samples) are reported. All results are presented in Tables 2e5. The distribution of tumour locations for the investigated groups is presented in Supplementary Tables 2e5. The ORs for female dogs of developing an adenoma/adenocarcinoma were significantly higher than those for male dogs. Females presented with lower ORs for haemangioma/haemangiosarcoma and squamous cell carcinoma than males (Table 2) .
Neutered male dogs presented with higher ORs of developing the following tumours than entire male dogs: adenoma/adenocarcinoma, lymphoma, mast cell tumour and osteoma/osteosarcoma (Table 3) .
Neutered female dogs had lower ORs of developing adenoma/adenocarcinoma than entire females. Neutered female dogs presented with higher ORs for the following tumours: haemangioma/haemangiosarcoma, lymphoma, mast cell tumour and melanocytic tumour ( Table 3) .
Influence of Sex and Neutering Status on Tumour Location
Female dogs presented with higher ORs of developing mammary gland tumours than male dogs (Table 4) .
Neutered male dogs presented with higher ORs for skin tumours, tumours of the blood and the haemopoietic system, tumours of the endocrine glands, the respiratory system and intrathoracic organs and unspecified locations than entire male dogs (Table 5) .
Neutered female dogs presented with higher ORs for skin and soft tissue tumours, tumours of the blood and the haemopoietic system, the gastrointestinal tract, the oral cavity and pharynx, the respiratory system and intrathoracic organs and the urinary organs than entire female dogs. They had lower ORs for tumours of the mammary gland (Table 5 ).
To verify the results above, the investigations for neutered females versus entire females were repeated, excluding tumours of the mammary gland. The deviations from the results that included mammary gland tumours were negligible ( Supplementary Tables  6e7 ). An exception was the result for adenoma/ adenocarcinoma in post-mortem samples: neutered females had a higher risk for adenoma/adenocarcinoma than entire females when mammary tumours were excluded.
Discussion
The exceptionally large data set of the Swiss Canine Cancer Registry allowed multiple logistic regression, which was not always possible in the case of other registries and renders comparisons difficult. However, the data sets may be biased over time and further confounders could substantially influence the results. To overcome such influences specifically and to raise sensitivity, more general diagnostic terms were used. Further obstacles to comparison are typical issues related to the reproducibility of diagnoses in pathol-ogy, due to criteria for certain diagnoses changing over time and to the clearly subjective factor in histopathological diagnoses (Brønden et al., 2007; Pospischil and Folkers, 2015) . In this study, the influence of different time periods on techniques and state of the art in tumour diagnoses was taken into account by including the year of diagnosis as a variable in the statistical evaluation.
For the sake of simplicity only findings determined to be significant in the present work will be discussed below, while discussion of previously described results not confirmed by the present analysis will be omitted.
Adenoma/adenocarcinoma was the most frequent tumour diagnosis in dogs. Its relative proportion in total tumour diagnoses dropped from 40. 6% in 1980 6% in to 12.3% in 2008 6% in . In 1980 .80% of all examined canine patients (n ¼ 2,194) were entire. However, the relative proportion of entire animals decreased to 55.6% of total patients (n ¼ 7,879) in 2008. Since over 60% of the adenomas/adenocarcinomas were found in the sexual organs, the increasing tendency to neuter dogs could be one reason for the decrease in relative frequency of adenoma/adenocarcinoma. A similar tendency was observed for canine mammary cancers in Italy by Merlo et al. (2008) . Another aspect is the refinement in diagnostics over time, leading to a broader diversity of tumour diagnoses. Table 5 Risk of developing a tumour in the most common locations, comparing neutering status and sampling methods
Tumour location
Neutered males versus entire males (OR ¼ 1) Neutered females versus entire females (OR ¼ 1)
In The relative frequency of mast cell tumours, melanocytic tumours and haemangioma/haemangiosarcoma rose fairly constantly from 1955 to 2008. Since neutered female dogs are more frequently affected by these tumour types, the increase in neutering frequency over time might be partly responsible for this development. Vascellari et al. (2009) reported a frequency of 3% for canine lymphomas in the animal tumour registry of two provinces in Northern Italy between 2005 and 2008, which is comparable with our data (4.88% lymphomas).
The relative frequency of fibroma/fibrosarcoma increased from 6.52% in 1955 to 10.76% in 1996 and decreased to 5.41% in 2008. These results are in contrast with the increase in feline fibroma/fibrosarcoma (20%) observed in Switzerland in the 1990s (Graf et al., 2016) . However, in cats a strong connection between vaccination and the development of sarcomas at sites of injection is under discussion (Henry, 2013) . Such a connection has not been observed consistently in dogs.
The peaks in the relative frequency of tumour types between 1996 and 1999 were due to very high numbers of the respective tumours in the data sent in by the Vetsuisse Faculty Institut f€ ur Tierpathologie, Bern (ITPA). It is likely that these sudden increases were artificially generated by tumour studies in the institute. This is an example of factors that can skew tumour frequencies in the present study setting.
It is a well-known fact that overall tumour risk increases with age. In our data this was confirmed for adenoma/adenocarcinoma, melanocytic tumours and squamous cell carcinoma. Interestingly, the following tumour types in our study showed a frequency pattern deviating from that described above. The lymphoma risk peaked at 6 years of age. This finding is comparable with results of an Italian study (Merlo et al., 2008) , but contradicts data from another study from Italy, which did not, however, perform multivariate statistics (Vascellari et al., 2009 ). There was no clear age-related incidence of haemangioma/ haemangiosarcoma and mast cell tumour in patients >5 years of age. This could indicate the influence of the genetic background or other external factors.
Findings related to the effect of neutering status on tumour development were partly dependent on the examination method, specifically on whether the animal was dead or alive at the time of diagnosis. Overall tumour incidence in post-mortem samples was higher in neutered than in entire dogs, suggesting bias through investigation of mammary glands and testes in ex-vivo materials. The difference of the ORs for specific tumours in female dogs compared with male dogs was small in both sampling groups. Females were at a lower risk for haemangioma/haemangiosarcoma and squamous cell carcinoma compared with males, while they had a 33.7% higher risk for adenoma/adenocarcinoma overall. In postmortem samples the risk was only 10.6% higher for females than for males. However, when the neutering status was taken into consideration, the difference between the sampling groups was higher, confirming the suggested bias mentioned above.
Neutered dogs were shown to have a higher risk of developing tumours in various locations other than the sexual organs, which is consistent with data from other studies (Brønden et al., 2010; Torres de la Riva et al., 2013; Zink et al., 2014) . Other authors report that tumour risk in the mammary glands in entire dogs is higher than in neutered animals, a finding supported by our data (MacVean et al., 1978; Porrello et al., 2006; Brønden et al., 2010; Henry, 2013) .
Neutered male and female dogs showed higher ORs for lymphoma and mast cell tumour. Neutered female dogs additionally showed higher ORs for melanocytic tumours and haemangioma/haemangiosarcomas, as did neutered male dogs for adenoma/ adenocarcinoma and osteoma/osteosarcoma. These correlations need to be validated by future research.
In the present study, breed predispositions for neoplasia in general, arranged in descending order, were recorded in boxers, cocker spaniels, poodles, Swiss mountain dogs, dachshunds, setters, schnauzers and retrievers. In contrast, Great Danes, bulldogs, West Highland white terriers, Parson Jack Russell terriers, rottweilers, dobermanns, collies, shepherds and Yorkshire terriers showed a lower risk of developing a tumour compared with crossbreds.
Other authors report the boxer, the flat coated retriever and the golden retriever (subsets of the category of retriever in our study), the Bernese mountain dog and the Saint Bernard (subsets of the Swiss mountain dog) and the giant schnauzer (a subset of schnauzer) as being more susceptible to tumour development (Brønden et al., 2010; Bell et al., 2012; Dobson, 2013) . German shepherd dogs were at a lower risk of tumour development in the Danish Veterinary Cancer Registry (Brønden et al., 2010) . These findings are roughly confirmed by our study, taking into account the differences in breed allocation.
For a better overview and clinical relevance we hereafter only discuss outstanding results of the influence of breed on the development of some specific tumours.
The boxer had an almost five times higher risk (OR 4.926 [CI ¼ 4.343, 5 .587]) of developing a mast cell tumour and a 1.85 times higher risk of haemangioma/haemangiosarcoma (OR 1.850 [CI ¼ 1.506, 2.261]). Similar findings have been described in the literature (Misdorp, 2004; Gough and Thomas, 2010) .
Schnauzers were two times more susceptible for melanocytic tumour and seven times more susceptible for squamous cell carcinoma than crossbreds. Melanocytic tumour is known to occur more frequently in dogs with darkly pigmented skin or oral mucosa (e.g. schnauzers) (Gough and Thomas, 2010; Dobson, 2013) . The OR for squamous cell carcinoma in the schnauzer was higher than expected, which might indicate either a genetic or an environmental factor associated with the geographical area from which the samples originate. Gough and Thomas (2010) report a predisposition of the schnauzer for squamous cell carcinoma of the digit in a case series.
The shepherd had higher ORs (OR 1.806 [CI ¼ 1.518, 2.150]) of developing a haemangioma/ haemangiosarcoma, which is consistent with previous reports (Gough and Thomas, 2010) .
The rottweiler (OR 3.321 [CI ¼ 2.321, 4.752]) and the Great Dane (OR 1.936 [CI ¼ 1.248, 3.003]) had a higher risk of developing an osteoma/osteosarcoma. This tendency has also been reported in the literature (Gough and Thomas, 2010) . Reported risk factors for canine osteosarcoma are high weight, high height, early neutering and breed predisposition (e.g. Irish wolfhound, Saint Bernard, Great Dane, rottweiler, Irish setter, dobermann, golden retriever, Labrador retriever and Leonberger) (Porrello et al., 2006; Butler et al., 2013) . Genetic factors have been observed to differentiate rottweilers and golden retrievers with regard to the incidence of spontaneous appendicular osteosarcoma, independent of sex, age and histological classification (Thomas et al., 2009) . The most significant difference was the deletion of the WT1 gene in 48% of the rottweiler tumour cases, while this did not occur in any of the golden retrievers. A recent study suggests that 'weight-bearing stress during the period of high proliferative activity in the long bones associated with growth may increase the risk of canine primary bone cancer' (Anfinsen et al., 2015) .
There was, in the present study, no significant difference between mixed breeds and the examined breeds/breed categories with regard to general cancer risk, which contrasts with the report of Brønden et al. (2007) , who showed a twofold increased risk of developing tumours for pure breeds compared with mixed breeds. Vascellari et al. (2009) , in addition, described the estimated crude annual incidence rate for malignant tumours as twofold higher in purebred dogs than in crossbreed dogs (Vascellari et al., 2009 ). Different data collecting or breed definition standards might be the reason for these contradictory results. Since the declaration of breed is usually provided by the owner of the dog, it is necessary to avoid future uncertainties related to breed declaration through genetic testing. Today, the examination of the genome of dogs and the identification of single nucleotide polymorphism (SNP) haplotypes allows the classification of dog breeds on the basis of genetic relationship (Vonholdt et al., 2010) . This will be addressed in a follow-up study. Additionally, the breed-related risks found in the present study were confirmed through analysis of the newest data from the Swiss Canine Cancer Registry of 2009e2013 (data not shown).
Small breeds were at a higher risk of developing tumours of the mammary gland and the endocrine glands than large breeds. The following tumour locations were less likely in small breeds than in large breeds: the respiratory system and intrathoracic organs, the blood and haemopoietic system, soft tissues, skin, retroperitoneum and peritoneum, other female sexual organs, bones, joints and articular cartilage. Contrasting findings, such as a lower malignant mammary tumour incidence in small breed dogs, are suggested by Itoh et al. (2005) . Further investigations will be necessary to verify those results. The unexpectedly high risk of developing tumours of the mammary glands for small breeds in our data could be explained by their tendency to have shorter sexual cycles (Arnold-Gloor et al., 2011) and therefore increased exposure to sex hormones during oestrus.
The breeds/breed categories with lower risk of developing osteoma/osteosarcoma were breeds of small body size, with the exception of poodles and schnauzers, which show varying body sizes. These results suggest that size and castration are predisposing factors for skeletal tumours.
The large sample size in the present study allowed a detailed insight into the occurrence of the most common tumour diagnoses over time and into the influences of age, breed, body size, sex and neutering status on canine tumour development. Through the inclusion of influencing variables in the statistics, bias factors such as the examination method or the year of diagnosis were controlled. Naturally, not all environmental tumour risk factors were recorded in this retrospective cancer registry and therefore could not be included in the statistical evaluation. The clinical relevance still has to be elucidated.
In many cases, the results of the analysis of the Swiss Canine Cancer Registry confirm the findings of other authors. In some cases, the results were unique or contradicted other studies, implying that further investigations are necessary.
The reproducibility of cancer epidemiological studies is greatly affected by the absence of international standards for veterinary cancer registries (Brønden et al., 2007) . In addition, the lack of guidelines leads to enormous differences in data collection and consolidation methods among existing veterinary cancer registries (Brønden et al., 2007; Vascellari et al., 2009) . To achieve a more accurate comparison it is crucial to define international de jure standards for veterinary cancer registries. It is desirable to collect even more primary information from the canine tumour patient for further epidemiological studies of canine cancer, such as type of treatment, diet, age at neutering, obesity (body mass index) and body size, the presence of other diseases, vaccination status and environmental factors (e.g. exposure to cigarette smoke and other husbandry conditions, daily exercise).
